Press release
Anti-Inflammatory Drugs Market to Reach USD 198.92 Billion by 2031 | Leading key players - AbbVie Inc., Johnson & Johnson Services, Inc., Pfizer Inc.
Anti-Inflammatory Drugs Market
The Anti-Inflammatory Drugs Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/anti-inflammatory-drugs-market?sz
The Anti-Inflammatory Drugs Market comprises medications used to reduce inflammation, alleviate pain, and treat conditions such as arthritis, asthma, and autoimmune diseases. These drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. Market growth is driven by increasing chronic disease prevalence, aging populations, and advancements in drug formulations to enhance efficacy and minimize side effects.
Prominent Industry players in the Anti-Inflammatory Drugs Market
The prominent players in Anti-Inflammatory Drugs market research report are: AbbVie Inc., Johnson & Johnson Services, Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Novartis AG, Amgen Inc., GSK plc, Merck & Co., Inc., Bristol-Myers Squibb Company, and Viatris Inc. among others.
Emerging Players: UCB S.A., Rapport Therapeutics, and Apogee Therapeutics, Inc. among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Industry News
In July 2024, Hikma Pharmaceuticals PLC announced a major milestone as the U.S. Centers for Medicare and Medicaid Services (CMS) granted a unique, permanent HCPCS J-code for COMBOGESIC IV a non-opioid intravenous formulation combining acetaminophen and ibuprofen. This approval supports broader accessibility and reimbursement for adult pain management without the use of opioids.
In July 2024, Alembic Pharmaceuticals received final approval from the U.S. FDA for its Bremen Ophthalmic Solution, 0.07%. This NSAID medication is intended for use after cataract surgery, helping to reduce ocular pain and manage postoperative inflammation, offering patients an effective nonsteroidal option for eye care recovery.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/anti-inflammatory-drugs-market
Market Segments
By Drug Class: Anti-Inflammatory Biologics, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs), Others.
By Application: Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Asthma, Tendonitis, Others.
By Route of Administration: Oral, Injection, Inhalation, Topical.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
The Anti-Inflammatory Drugs industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.
Regions Covered:
The global Anti-Inflammatory Drugs Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
FAQs:
✒ What is driving the growth of the Anti-Inflammatory Drugs Market?
✒ Who are the prominent players in the Anti-Inflammatory Drugs Market?
✒ How is the regulatory landscape affecting the Anti-Inflammatory Drugs Market?
✒ What regions are expected to see the highest growth?
✒ What are the key challenges faced by the Anti-Inflammatory Drugs Market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Looking for Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=anti-inflammatory-drugs-market?sz
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Inflammatory Drugs Market to Reach USD 198.92 Billion by 2031 | Leading key players - AbbVie Inc., Johnson & Johnson Services, Inc., Pfizer Inc. here
News-ID: 4077143 • Views: …
More Releases from DataM Intelligence 4Market Research
Chronic Pain Treatment Market Set to Surge with Breakthrough Therapies and Risin …
The Global Chronic Pain Treatment Market reached US$ 83.8 billion in 2022 and is expected to reach US$ 143.2 billion by 2030 growing with a CAGR of 7.1% during the forecast period 2024-2031.
The Chronic Pain Treatment Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies,…
Stress Urinary Incontinence Market Surges as Minimally Invasive Solutions and Ag …
The Stress Urinary Incontinence Market is expected to reach a CAGR of 6.91% during the forecast period 2024-2031.
The Stress Urinary Incontinence Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.
Unlock exclusive insights with our…
Agricultural Inoculants Market Set to Soar as Sustainable Farming Gains Momentum …
The Global Agricultural Inoculants Market reached US$ 9.21 billion in 2022 and is expected to reach US$ 21.24 billion by 2031, growing with a CAGR of 11.01% during the forecast period 2024-2031.
The Agricultural Inoculants Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product…
Crankcase Ventilation Market Surges with Emissions Control Demand and Engine Eff …
The Global Crankcase Ventilation Market reached US$ 24.6 Billion in 2023 and is expected to reach US$ 36.7 Billion by 2031, growing with a CAGR of 5.2% during the forecast period 2024-2031.
The Crankcase Ventilation Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
